KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial.

J Clin Oncol · 2026-Jan · PMID 41115255

Panel D质量警告待 EXE 对齐验证

OS

FIG 2. Kaplan-Meier estimates for EFS and OS. (A) EFS in the modified intention-to-treat population in the platinum and control arms. (B) EFS in premenopausal patients in the platinum and control arms. (C) EFS in postmenopausal patients in the platinum and control arms. (D) OS in the modified intention-to-treat population in the platinum and control arms. (E) OS in premenopausal patients in the platinum and control arms. (F) OS in postmenopausal patients in the platinum and control arms. All P values are derived from unstratified, two-sided log-rank tests. P values for secondary end points and subgroup analyses are nominal. EFS, event-free survival; OS, overall survival.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.72
质量通过否
预期曲线2
实际曲线1
X 范围0 – 144
Y 范围0 – 70

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 17 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
110.04320.21326.225413.9199410513
120.04390.21326.327413.9199411513
130.04460.21326.429513.9199412513
140.04540.21326.531513.9199413513
150.04610.21326.633613.9199414513
160.04680.21326.735613.9199415513
170.04750.21326.837713.9199416513
180.04820.21326.939813.9199417513
190.04890.21327.041813.9199418513
1100.04960.21327.143913.9199419513
1110.05030.21327.245913.9199420513
1120.05100.21327.348013.9199421513
1130.05170.21327.450013.9199422513
1140.05240.21327.552113.9199423513
1150.05320.21327.654113.9199424513
1160.05390.21327.756213.9199425513
1170.05460.21327.858313.9199426513
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-23T17:14:08+00:00